Vaccine and antibody treatment effectiveness blunted by all three Omicron subvariants — ScienceDaily
Only one currently authorized antibody treatment retains its activity against all Omicron subvariants, according to new research by scientists at Columbia University and the University of Hong Kong. The study…
